Sunday, September 09, 2018 -- Roche faces a fresh row over drug pricing in Britain, following a decision by the body responsible for medicine use within the state health service not to approve its drug Ocrevus for treating a highly disabling form of multiple sclerosis (MS).
Monday, September 03, 2018 -- In a recent clinical study, ibudilast slowed brain shrinkage better than a placebo in the brains of patients with multiple sclerosis... The post Multiple sclerosis drug slows brain shrinkage...
Tuesday, September 04, 2018 -- A team of researchers the University of Zurich and the University Hospital Zurich has shown that in multiple sclerosis, it is not only specific T cells that cause inflammation and lesions in the brain.
Tuesday, September 04, 2018 -- Demyelination, neuroaxonal, and astroglial damage in the white matter are contributors to the lass of structural connectivity in multiple sclerosis.
Thursday, August 30, 2018 -- MedicalResearch.com Interview with: Robert J. Fox, MD, FAAN Principal Investigator | SPRINT-MS Trial Mellen Center for MS | Cleveland Clinic Cleveland, OH 44195 MedicalResearch.com: What is the background for this study? What are the main findings? Response: The current treatment … Continue reading →
Monday, September 03, 2018 -- A recent study looked at whether exposure to paint and other organic solvents are among the causes of multiple sclerosis in people who are genetically susceptible to the disease. Multiple sclerosis is a debilitating autoimmune disease of the central nervous system, which includes the brain and spinal cord. Symptoms of multiple sclerosis differ from person […] The post Do multiple sclerosis causes include exposure to paint and other solvents? appeared first on Medical News Bulletin | Health News and Medical Research.
Thursday, September 06, 2018 -- BACKGROUND AND PURPOSE: Alterations of neck vessel cross-sectional area in multiple sclerosis have been reported. Our aim was to investigate the evolution of the neck vessel cross-sectional area in patients with MS and healthy controls during 5 years. MATERIALS AND METHODS: Sixty-nine patients with MS (44 relapsing-remitting MS, 25 progressive MS) and 22 age- and sex-matched healthy controls were examined twice, 5 years apart, on a 3T MR imaging scanner using 2D neck MR angiography. Cross-sectional areas were computed for the common carotid/internal carotid arteries, vertebral arteries, and internal jugular veins for all slices between the C3 and C7 cervical levels. Longitudinal cross-sectional area differences at each cervical level and the whole-vessel course were tested within study groups and
Thursday, August 30, 2018 -- The multiple sclerosis field has been a hotbed for payers pressing drugmakers to trade formulary spots for discounts. But that’s changed a bit in 2018—and a few companies stand to reap the benefits.
Thursday, August 23, 2018 -- (MedPage Today) -- Finding may open new research targets
Thursday, September 20, 2018 -- Investigators examined the effects of smoking on respiratory symptoms and functional levels in patients with multiple sclerosis.
Tuesday, September 11, 2018 -- Investigators sought to determine characteristics of multiple sclerosis prodrome by analyzing data from healthcare settings.
Tuesday, September 18, 2018 -- Cognitive function was assessed in patients with multiple sclerosis who were treated with natalizumab for 2 or more years.
Thursday, August 23, 2018 -- Investigators examine identifiers to predict disability in patients with relapsing-onset multiple sclerosis.